- Report
- May 2026
- 80 Pages
Europe
From €2990EUR$3,250USD£2,498GBP
- Report
- May 2026
- 76 Pages
Asia Pacific
From €2990EUR$3,250USD£2,498GBP
- Report
- February 2026
- 150 Pages
United States
From €4463EUR$4,850USD£3,727GBP
- Report
- April 2026
North America
From €3174EUR$3,450USD£2,651GBP
- Report
- March 2026
North America
From €3174EUR$3,450USD£2,651GBP
- Report
- June 2026
- 270 Pages
Asia Pacific
From €1380EUR$1,500USD£1,153GBP
- Report
- March 2026
- 199 Pages
United States
From €4463EUR$4,850USD£3,727GBP
- Report
- December 2025
- 150 Pages
United States
From €4463EUR$4,850USD£3,727GBP
- Report
- August 2019
- 264 Pages
Global
From €3676EUR$3,995USD£3,070GBP
- Report
- December 2024
- 332 Pages
Global
From €3862EUR$4,197USD£3,225GBP
- Report
- May 2024
- 311 Pages
Global
From €5391EUR$6,064USD£4,350GBP
- Report
- June 2025
- 463 Pages
Global
From €5391EUR$6,064USD£4,350GBP
- Report
- July 2024
- 235 Pages
Global
From €5391EUR$6,064USD£4,350GBP
- Report
- October 2022
- 213 Pages
Global
From €4895EUR$5,506USD£3,950GBP
- Report
- April 2024
- 270 Pages
Global
From €4601EUR$5,000USD£3,842GBP
- Report
- February 2022
- 272 Pages
Global
From €5521EUR$6,000USD£4,611GBP
- Report
- August 2025
- 155 Pages
Global
From €2438EUR$2,650USD£2,037GBP
- Report
- March 2025
- 451 Pages
Global
From €4555EUR$4,950USD£3,804GBP
- Report
- February 2024
- 408 Pages
Global
From €4555EUR$4,950USD£3,804GBP
- Report
- November 2023
- 157 Pages
Global
From €2162EUR$2,350USD£1,806GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more